Clinical Trial Update: Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is investigating Cytokine-Induced Memory-Like Natural Killer (CIML-NK) cells as a treatment for relapsed or refractory acute myeloid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: RECRUITING